Prenatal diagnosis of oculocutaneous albinism type I: Review and personal experience

Pediatric and Developmental Pathology

Volumn 2, Issue 5, 1999, Pages 404-414

  Rosenmann, Eliezer ^a,b   Rosenmann, Ada ^a   Ne'eman, Zvi ^a   Lewin, Aby ^a   Bejarano Achache, Idit ^a   Blumenfeld, Anat ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Albinism; Electron microscopy; Melanogenesis; Mutation; Prenatal diagnosis; Tyrosinase

Indexed keywords

MONOPHENOL MONOOXYGENASE;

ALBINISM; AUTOSOMAL RECESSIVE DISORDER; ELECTRON MICROSCOPY; FETUS; GENE MUTATION; GENETIC COUNSELING; GENETIC DISORDER; HUMAN; OCULAR ALBINISM; OCULOCUTANEOUS ALBINISM; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW;

ALBINISM, OCULOCUTANEOUS; AMNION; BIOPSY; DNA; DNA MUTATIONAL ANALYSIS; FETAL DISEASES; HUMANS; LINKAGE (GENETICS); MELANINS; MELANOSOMES; MICROSCOPY, ELECTRON; PRENATAL DIAGNOSIS; SCALP;

EID: 0032864824     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100249900143     Document Type: Review

References (39)

1. King RA, Hearing VJ, Creel DJ, Oetting WS. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th ed. New York: McGraw-Hill, 1995;4353-4392.
2. Spritz AR, Hearing VJ. Genetic disorders of pigmentation. Adv Hum Genet 1994;22:1-45.
3. Oetting WS, King RA. Molecular basis of oculocutaneous albinism. J Invest Dermatol 1994;103:131S-136S.
4. Oetting WS, Brilliant MH, King RA. The clinical spectrum of albinism in humans. Mol Med Today 1996;2:330-335.
5. Spritz RA. Molecular genetics of oculocutaneous albinism. Semin Dermatol 1993;12:167-172.
6. Spritz RA. Molecular genetics of oculocutaneous albinism. Hum Mol Genet 1994;3:1469-1475.
7. Giebel LB, Tripathi RK, Strunk KM, et al. Tyrosinase gene mutations associated with type IB ("yellow") oculocutaneous albinism. Am J Hum Genet 1991;48:1159-1167.
8. Gershoni-Baruch R, Rosenmann A, Droetto S, Holmes S, Tripathi RK, Spritz RA. Mutations of the tyrosinase gene in patients with oculocutaneous albinism from various ethnic groups in Israel. Am J Hum Genet 1994;54:586-594.
9. Spritz RA, Oh J, Fukai K, et al. Novel mutations of the tyrosinase (TYR) gene in type I oculocutaneous albinism. Hum Mutat 1997;10:171-174.
10. Lee S-T, Nicholls RD, Bundey S, Laxova R, Musarella M, Spritz RA. Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism. N Engl J Med 1994;330:529-534.
11. Spritz RA, Lee S-T, Fukai K, et al. Novel mutations of the P gene in type II oculocotaneous albinism (OCA II). Hum Mutat 1997;10:175-177.
12. Oetting WS, Witkop CJ, Brown SA, et al. A frequent tyrosinase gene mutation associated with type 1-A (tyrosinase negative) oculocutaneous albinism in Puerto Rico. Am J Hum Genet 1993;52:17-23.
13. Tripathi RK, Bundey S, Musarella A, et al. Mutations of the tyrosinase gene in Indo-Pakistani patients with type 1 (tyrosinase-deficient) oculocutaneous albinism (OCA). Am J Hum Genet 1993;53:1173-1179.
14. Park SK, Lee KH, Park KC, Lee JS, Spritz RA, Lee ST. Prevalent and novel mutations of the tyrosinase gene in Korean patients with tyrosinase-deficient oculocutaneous albinism. Mol Cells 1997;7:187-191.
15. Bassi T, Schiaffino MV, Renieri A, et al. Cloning of the gene for ocular albinism type I from the distal short arm of the X chromosome. Nat Genet 1995;10:13-19.
16. Fukai K, Holms SA, Lucchese NJ, et al. Autosomal recessive ocular albinism associated with a functionally significant tyrosinase gene polymorphism. Nat Genet 1995;9: 92-95.
17. Schnur RE, Gao M, Wick PA, et al. OA1 mutations and deletions in X-linked ocular albinism. Am J Hum Genet 1998;62:800-809.
18. Sagebiel RA, Odland GF. Ultrastructural identification of melanocytes in early human embryo. In: Riley V, ed. Pigmentation; Its Genesis and Biologic Control. New York: Appleton-Century Crofts, 1972;43-50.
19. Hayenes ME, Robertson E. Can oculocutaneous albinism be diagnosed prenatally? Prenat Diagn 1981;1:81-89.
20. Eady RAG, Gunner DB, Graner A, Rodeck CH. Prenatal diagnosis of oculocutaneous albinism by electron microscopy. J Invest Dermatol 1983;80:210-212.
21. Rosenmann A, Levin A, Ne'eman Z, Yanku L, Shenker Y, Rosenmann E. Prenatal diagnosis of oculocutaneous albinism. J Isr Med Assoc 1991;120:703-704.
22. Gershoni-Baruch R, Benderly A, Brandes JM, Gilhar A. Dopa reaction test in hair bulbs of fetuses and its application to the prenatal diagnosis of albinism. J Am Acad Dermatol 1992;24:220-222.
23. Shimizu H, Ishiko A, Kikuchi A, Akiyama M, Suzumori K, Nishikawa T. Prenatal diagnosis of tyrosinase-negative oculocutaneous albinism [letter]. Lancet 1992;340:739-740.
24. Shimizu H, Ishiko A, Kikuchi A, Akiyama M, Suzumori K, Nishikawa T. Prenatal diagnosis of tyrosinase negative oculocutaneous albinism by electron microscopic dopa reaction test of fetal skin. Prenat Diagn 1994;14:442-450.
25. Kikuchi A, Shimizu H, Nishikawa T. Epidermal melanocytes in normal and tyrosinase-negative albinism fetuses. Arch Dermatol Res 1995;287:529-533.
26. Oetting WS, Fryer JP, King RA. A dinucleotide deletion (-GA115) in the tyrosinase gene responsible for type 1-A (tyrosinase negative) oclocutaneous albisim in a Pakistani individual. Hum Mol Genet 1993;2:1047-1048.
27. Matsunaga J, Dakeishi M, Miyamura Y, Tomita Y. Sequence analysis of the human tyrosinase promoter from a patient with tyrosinase-negative oculocutaneous albinism. Pigment Cell Res 1997;10:64-67.
28. Oetting WS, King RA. Molecular basis of type I (tyrosinase related) oculocutaneous albinism: mutations and polymorphisms of the human tyrosinase gene. Hum Mutat 1993;2: 1-6.
29. Welch WH. Genome Data Base (GDB), Medical Library, Baltimore MD.
30. Eady RAJ. Prenatal diagnosis of oculocutaneous albinism: implications for other hereditary disorders of pigmentation. Semin Dermatol 1984;3:241-246.
31. Shimizu H. Technical advances in prenatal diagnosis of tyrosinase-negative oculocutaneous albinism. Acta Dermatol Venereol 1997;77:10-13.
32. Shimizu H, Niizeki H, Suzumori K, et al. Prenatal diagnosis of oculocutaneous albinism by analysis of the fetal tyrosinase gene. J Invest Dermatol 1994;103:104-106.
33. Tomita Y, Takeda A, Matsunaga J, Okinaga S, Shibahara S, Tagami H. Molecular bases of tyrosine-negative oculocutaneous albinism: a single base insertion or a missense point mutation in the tyrosinase gene. Pigment Cell Res Suppl 1992;2:96-100.
34. Lee ST, Park SK, Lee H, Lee JS, Park YW. DNA-based prenatal diagnosis of a Korean family with tyrosinase-related oculocutaneous albinism (OCA I). Jpn J Hum Genet 1997;42:499-505.
35. Tsai FJ, Wu JY, Lin SP, Yang CF, Peng CT, Tsai CH. Molecular analysis of type I oculocutaneous albinism in Taiwanese. Am J Hum Genet 1998;63:A389.
36. Falik-Borenstein TC, Holmes SA, Borochowitz Z, Levin A, Rosenmann A, Spritz RA. DNA-based carrier detection and prenatal diagnosis of tyrosinase-negative oculocutaneous albinism (OCA IA). Prenat Diagn 1995;15:345-349.
37. Blumenfeld A, Slaugenhaupt SA, Axelrod FB, et al. Localisation of the gene for familial dysautonomia on chromosome 9 and definition of DNA markers for genetic diagnosis. Nat Genet 1993;4:160-164.
38. Park KC, Kim KH, Lee YS, Kwon BS. Single-strand conformation polymorphism analysis of point mutation in tyrsinase-negative oculocutaneous albinism. J Inherit Metab Dis 1994;17:123-126.
39. Oetting WS, Fryer PJ, Oofuji Y, et al. Analysis of tyrosinase gene mutations using direct automated infrared fluorescence DNA sequencing of amplified exons. Electrophoresis 1994;15:159-164.